Gritstone Oncology, Inc. Business Finance Contracts & Agreements
19 Contracts & Agreements
- Financing Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (1)
- Purchase Agreements (4)
- Stock Agreements (5)
- Underwriting Agreements (3)
- Warrant Agreements (4)
- Senior Secured Super Priority Debtor-In-Possession Financing Agreement, dated as of November 13, 2024, by and among Gritstone bio, Inc., the lenders from time to time party... (Filed With SEC on November 15, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 2, 2024)
- Form of Common Stock Warrant (Filed With SEC on April 2, 2024)
- Underwriting Agreement, dated April 1, 2024 (Filed With SEC on April 2, 2024)
- First Amendment to Loan and Security Agreement, dated as of March 31, 2023, by and among Gritstone bio Inc., as borrower, Silicon Valley Bank, a division of First-Citizens Bank &... (Filed With SEC on April 6, 2023)
- Securities Purchase Agreement, dated October 24, 2022 (Filed With SEC on October 25, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on October 25, 2022)
- Description of Common Stock (Filed With SEC on March 10, 2022)
- Securities Purchase Agreement, dated September 16, 2021 (Filed With SEC on September 17, 2021)
- Stock Purchase Agreement, dated January 29, 2021 (Filed With SEC on February 1, 2021)
- Securities Purchase Agreement, dated December 28, 2020 (Filed With SEC on December 30, 2020)
- Securities Purchase Agreement, dated December 22, 2020 (Filed With SEC on December 28, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on December 28, 2020)
- Description of Common Stock (Filed With SEC on March 11, 2020)
- Form of Underwriting Agreement (Filed With SEC on April 22, 2019)
- 2018 Employee Stock Purchase Plan (Filed With SEC on September 17, 2018)
- Form of Common Stock Certificate (Filed With SEC on September 17, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 17, 2018)
- Amended and Restated Investors Rights Agreement dated as of June 29, 2018, by and among Gritstone Oncology, Inc. and the investors listed therein (Filed With SEC on August 23, 2018)